add items to your
binder to email or
print all at once
Items In Binder
Site Lawyers
Johnson & Johnson's Acquisition of Ci:z Holdings Co., Ltd

On October 23, 2018, Johnson & Johnson announced that it has agreed with Ci:z Holdings Co., Ltd. (the “Company”), a Japanese company focused on the marketing, development and distribution of a broad range of dermocosmetic, cosmetic and skincare products, to launch an all‑cash offer to acquire all of the outstanding shares of the Company not already held by Johnson & Johnson and its affiliates for approximately ¥230 billion. The acquisition will include the Company’s range of brands comprising Dr.Ci:Labo, Labo Labo and Genomer line of skincare products. Cravath is representing Johnson & Johnson in connection with the transaction.

The Cravath team is led by partners Robert I. Townsend III and Damien R. Zoubek and includes associate Aashim Usgaonkar on M&A matters, and partner J. Leonard Teti II and associate Andrew T. Davis on tax matters.